文献速递复苏、休克与脓毒症消化、代谢与肾脏急症

无发热与急诊疑似感染性休克患者住院死亡率升高及抗生素和静脉输液减少相关

The Absence of Fever Is Associated With Higher Mortality and Decreased Antibiotic and IV Fluid Administration in Emergency Department Patients With Suspected Septic Shock.
PubMed 文献 · Crit Care Med · 2017-01-01
一句话结论急诊感染性休克患者中,无发热者急诊抗生素使用率更低、静脉输液量更少、住院死亡率更高,校正后无发热仍为住院死亡的独立预测因素。

本研究为前瞻性观察性研究的二次分析,纳入2012年11月11日至2013年9月23日期间在一家城市学术急诊科连续就诊的成人休克患者,限定为感染性休克。无发热定义为既无主观发热史、也无急诊记录体温>100.4°F。378例感染性休克患者中207例(55%,50-60%)有发热。无发热患者急诊抗生素使用率更低(81% vs 94%,p<0.01)、平均静脉输液量更少(2,607 vs 3,013 mL,p<0.01)、住院死亡率更高(33% vs 11%,p<0.01)。校正碳酸氢根<20 mEq/L、乳酸浓度、呼吸频率≥24次/分、急诊抗生素和急诊静脉输液量后,无发热仍是住院死亡的显著预测因素(OR 4.3,95%CI 2.2-8.2,AUC=0.83)。

要点

  • 急诊感染性休克无发热患者住院死亡率33%,显著高于发热患者的11%(p<0.01)。
  • 无发热患者急诊抗生素使用率81%,低于发热患者的94%(p<0.01)。
  • 无发热患者平均静脉输液量2,607 mL,少于发热患者的3,013 mL(p<0.01)。
  • 校正碳酸氢根<20 mEq/L、乳酸、呼吸频率≥24次/分、急诊抗生素和输液量后,无发热预测住院死亡OR 4.3(95%CI 2.2-8.2,AUC=0.83)。
  • 378例感染性休克患者中207例(55%,50-60%)有发热,无发热者占少数但死亡风险更高。

适用人群与场景

  • 成人(18岁及以上)急诊患者,符合以下任一休克标准:至少1L静脉输液后收缩压<90 mm Hg;需要新启用血管升压药;收缩压<90 mm Hg且因担心液体过负荷而暂缓静脉输液。
  • 本研究限定为感染性休克患者;发热组为急诊记录有主观发热史或测得体温>100.4°F,无发热组两者均无。

诊断标准与关键阈值

  • 发热:急诊记录主观发热史或测得体温>100.4°F;无发热:两者均无。

研究设计与关键结果

  • 研究类型:前瞻性观察性研究的二次分析;单家城市学术急诊科;连续纳入2012年11月11日至2013年9月23日成人休克患者。
  • 378例感染性休克患者中207例(55%,50-60%)有发热;无发热患者急诊抗生素使用率81% vs 发热患者94%(p<0.01)。
  • 无发热患者平均静脉输液量2,607 mL vs 发热患者3,013 mL(p<0.01)。
  • 无发热患者住院死亡率33% vs 发热患者11%(p<0.01)。
  • 校正碳酸氢根<20 mEq/L、乳酸浓度、呼吸频率≥24次/分、急诊抗生素和急诊静脉输液量后,无发热仍是住院死亡的显著预测因素(OR 4.3,95%CI 2.2-8.2,AUC=0.83)。

证据类型、等级与局限

  • 证据类型:前瞻性观察性研究的二次分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在急诊感染性休克患者中,无发热(无主观发热史且无测得体温>100.4°F)与急诊抗生素使用率更低、静脉输液量更少及住院死亡率更高相关。
  • 校正碳酸氢根<20 mEq/L、乳酸浓度、呼吸频率≥24次/分、急诊抗生素和急诊静脉输液量后,无发热仍预测住院死亡(OR 4.3,95%CI 2.2-8.2)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: This study evaluates whether emergency department septic shock patients without a fever (reported or measured) receive less IV fluids, have decreased antibiotic administration, and suffer increased in-hospital mortality.

DESIGN: This was a secondary analysis of a prospective, observational study of patients with shock.

SETTING: The study was conducted in an urban, academic emergency department.

PATIENTS: The original study enrolled consecutive adult (aged 18 yr or older) emergency department patients from November 11, 2012, to September 23, 2013, who met one of the following shock criteria: 1) systolic blood pressure less than 90 mm Hg after at least 1L IV fluids, 2) new vasopressor requirement, or 3) systolic blood pressure less than 90 mm Hg and IV fluids held for concern of fluid overload. The current study is limited to patients with septic shock. Patients were grouped as febrile if they had a subjective fever or a measured temperature >100.4°F documented in the emergency department; afebrile patients lacked both.

MEASUREMENTS AND MAIN RESULTS: Among 378 patients with septic shock, 207 of 378 (55%; 50-60%) were febrile by history or measurement. Afebrile patients had lower rates of antibiotic administration in the emergency department (81% vs 94%; p < 0.01), lower mean volumes of IV fluids (2,607 vs 3,013 mL; p < 0.01), and higher in-hospital mortality rates (33% vs 11%; p < 0.01). After adjusting for bicarbonate less than 20 mEq/L, lactate concentration, respiratory rate greater than or equal to 24 breaths/min, emergency department antibiotics, and emergency department IV fluids volume, being afebrile remained a significant predictor of in-hospital mortality (odds ratio, 4.3; 95% CI, 2.2-8.2; area under the curve = 0.83).

CONCLUSIONS: In emergency department patients with septic shock, afebrile patients received lower rates of emergency department antibiotic administration, lower mean IV fluids volume, and suffered higher in-hospital mortality.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Henning DJ, Carey JR, Oedorf K, et al. The Absence of Fever Is Associated With Higher Mortality and Decreased Antibiotic and IV Fluid Administration in Emergency Department Patients With Suspected Septic Shock. Crit Care Med. 2017. PMID: 28333759. doi:10.1097/CCM.0000000000002311

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。